Imiglucerase
CAS 154248-97-2Biologic
Overview
Imiglucerase is a recombinant DNA-engineered analogue of human β-glucocerebrosidase, an enzyme deficiency of which is associated with Gaucher's disease. It is used to catalyze the hydrolysis of glucocerebroside to glucose and ceramide.
Therapeutic areas
Genetic DisordersLysosomal Storage Disorders
Verified Supplier Partner
Do you supply Imiglucerase? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.